Studying the cell is a difficult and time-consuming process, but scientists have pinpointed generative AI as a potential way ...
“How difficult is it to make a cell type? How many of that cell type do you need? What’s the addressable market?” That’s the first line of questions that Brian Culley—CEO at Lineage Cell Therapeutics, ...
ATPG targets faults at IC-gate boundaries, but 50% of defects are located within cells. Learn how cell-aware ATPG and user-defined fault models help to ferret out these hard-to-squash bugs.